Ongentys blocks the enzyme that breaks down Levodopa, giving your brain more dopamine for longer. Here's how it works in plain English.
If your doctor has prescribed Ongentys (Opicapone) for your Parkinson's disease, you might be wondering: what exactly does this pill do? How does it help with those frustrating "off" episodes when your medication seems to stop working?
The short answer: Ongentys blocks an enzyme called COMT that would otherwise destroy your Levodopa before it can reach your brain. By protecting Levodopa, Ongentys helps it last longer — meaning more "on" time and fewer off episodes.
Let's break that down in plain English.
If you have Parkinson's disease, your brain isn't making enough dopamine — the chemical messenger that controls movement. Levodopa (usually combined with Carbidopa as Sinemet) is the gold standard treatment because your brain can convert it into dopamine.
But here's the catch: your body doesn't want all that Levodopa reaching your brain. An enzyme called COMT (catechol-O-methyltransferase) breaks down Levodopa in your bloodstream before it ever gets there. Think of COMT as a toll collector on the highway to your brain — it stops a portion of every Levodopa dose from getting through.
Ongentys is a COMT inhibitor. It temporarily blocks the COMT enzyme, like putting the toll collector on a break. With COMT out of the way:
The result? More "on" time (when your medication is working and symptoms are controlled) and fewer "off" episodes (when symptoms come back because the medication has worn off).
Imagine your Levodopa dose is a caravan of 100 supply trucks headed to your brain. Without Ongentys, the COMT enzyme acts like road closures, stopping 30-40 of those trucks from getting through. With Ongentys, those road closures are removed — more trucks make it to the destination, and the supplies (dopamine) last longer.
Ongentys starts working relatively quickly. After taking your dose, it begins inhibiting COMT within hours. However, the full clinical benefit — noticeable reduction in off episodes — typically becomes apparent within the first 1-2 weeks of daily use.
Because Ongentys affects how your body processes Levodopa, your doctor may need to adjust your Levodopa dose during this initial period. Many patients experience dyskinesia (involuntary movements) early on, which is usually a sign that more Levodopa is reaching the brain — and that a dose reduction may help.
One of Ongentys' biggest advantages is its duration. It provides sustained COMT inhibition for approximately 24 hours from a single dose. This is why it's taken just once daily at bedtime — one capsule covers you all day and night.
This long duration is possible because Opicapone binds tightly to the COMT enzyme, keeping it blocked even after the drug itself has been cleared from your bloodstream. It's what pharmacologists call a "slow off-rate" — Ongentys grabs onto COMT and doesn't let go easily.
Ongentys isn't the only COMT inhibitor available. Here's how it compares to the others:
Entacapone is the most commonly used COMT inhibitor, mainly because it's been around longer and has affordable generics (around $40-$50/month). But Entacapone must be taken with every dose of Levodopa — which can mean up to 8 doses per day. Ongentys' once-daily dosing is a major convenience advantage. Clinical studies also suggest Ongentys may provide slightly greater COMT inhibition than Entacapone.
Tolcapone is a more potent COMT inhibitor, but it comes with a serious risk: potentially fatal liver damage. Patients on Tolcapone require regular liver function tests. Ongentys does not carry this liver toxicity risk, making it a safer option.
Nourianz takes a completely different approach — it's an adenosine A2A receptor antagonist, not a COMT inhibitor. While both drugs reduce off time as add-ons to Levodopa, they work through different mechanisms. Some patients who don't respond well to one approach may benefit from the other.
Ongentys offers the best balance of convenience (once daily), safety (no liver monitoring required), and effectiveness (strong COMT inhibition). The main downside is cost — at $645 to $1,003 per month without insurance, it's significantly more expensive than generic Entacapone.
Ongentys works by protecting your Levodopa from being broken down too quickly, so more of it reaches your brain and lasts longer. It's a once-daily pill that provides 24-hour COMT inhibition — a real step forward in convenience compared to older options like Entacapone.
If you're experiencing off episodes despite your current Parkinson's regimen, Ongentys might help. Talk to your neurologist or movement disorder specialist about whether it's right for you. And when you're ready to fill your prescription, Medfinder can help you find a pharmacy with Ongentys in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
